FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/04/033039 [Registered on: 23/04/2021] Trial Registered Prospectively
Last Modified On: 22/04/2021
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To assess the effect of SanshodhanKarma i.e. Vaman and Virechan on lipid profile. 
Scientific Title of Study   A comparative clinical study to assess the effect of SanshodhanKarma i.e. Vaman and Virechan on lipid profile. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Gopesh Mangal 
Designation  Associate Professor 
Affiliation   
Address  PG Dept of Panchkarma National Institute of Ayurveda Jaipur

Jaipur
RAJASTHAN
302002
India 
Phone  8619849011  
Fax    
Email  gmangal108@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Gopesh Mangal 
Designation  Associate Professor 
Affiliation   
Address  PG Dept of Panchkarma National Institute of Ayurveda Jaipur

Jaipur
RAJASTHAN
302002
India 
Phone  8619849011  
Fax    
Email  gmangal108@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Vaibhav Bapat 
Designation  Panchkarma Vaidya 
Affiliation   
Address  PG Dept of Panchkarma National Institute of Ayurveda Jaipur

Jaipur
RAJASTHAN
302002
India 
Phone  8955473435  
Fax    
Email  vaibhavajitbapat@gmail.com  
 
Source of Monetary or Material Support  
National Institute of Ayurveda  
 
Primary Sponsor  
Name  National Institute of Ayurveda 
Address  Madhav Vilas Palace Jorahawar Singh gate Amer road Jaipur 302002 Rajasthan 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Gopesh Mangal  National Institute of Ayurveda  OPD room no 2 and IPD of Panchakarma Department , National Institute of Ayurveda, Jaipur 302002, Rajasthan
Jaipur
RAJASTHAN 
8619849011

gmangal108@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, National Institute of Ayurveda  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  300 relatively healthy individuals of either sex  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Vaman Karma  In group A Paachan with panchakolchurna 3gm for 7 days snehapaan with cow ghee in increasing dosage starting dose with 50ml and 25ml dose will be increased daily till the achievement of Samyaksnehalakshana. In group A Vaman will be done with Aakanthapaan of milk, Vamak yoga will be Madanfalpippalichurna 3gm, Kutajbeej churna 2gm, Patola patra 2gm madhu 10ml and saindhav 2gms, Madhuyashti faant with adequate quantity will be used as Vamanopag drug.  
Comparator Agent  Virechan Karma  In group B Paachan with panchakolchurna 3gm for 7 days snehapaan with cow ghee in increasing dosage starting dose with 50ml and 25ml dose will be increased daily till the achievement of Samyaksnehalakshana. In group B Triphala, Trivrit, Danti kwath 200ml will be given for Virechan.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Male or Female Subjects in the age group of 18 to 60 years, both inclusive.
2. Subjects who are willing to undergo sanshodhan karma.
3. Subjects of female gender or non-pregnant, non-lactating females. A urine pregnancy test
is required for all female subjects of childbearing potential unless subject has had a
hysterectomy, tubal ligation, or is > 2 years postmenopausal.
4. Subjects willing to follow the procedures as per the study protocol and voluntarily sign an
informed consent form 
 
ExclusionCriteria 
Details  1. Subjects with any known systemic disease.
2. Known cases of Severe/Chronic hepatic or renal disease.
3. Known case of any active malignancy.
4. Subjects giving history of significant cardiovascular event.
5. Subjects having known chronic, contagious infectious disease, such as active
tuberculosis, Hepatitis B or C, or HIV.
6. Pregnant and Lactating females.
7. Those who are contraindicated for sanshodhan karma. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
to evaluate changes in lipid levels after Ghritapan and Sanshodhan Karma.  Blood samples for lipid profile will be collected for each individual. On the day before paachan
karma, on the day before commencement of Snehapaan, Next day of completion of snehapaan
and after completion of SansarjanKrama and followup 15 days after sansarjan karma. 
 
Secondary Outcome  
Outcome  TimePoints 
To assess the probable risk factors of Ghritapan and Sanshodhankarma on the basis of lipid
levels 
On the day before paachan
karma, on the day before commencement of Snehapaan, Next day of completion of snehapaan
and after completion of SansarjanKrama and followup 15 days after sansarjan karma. 
 
Target Sample Size   Total Sample Size="300"
Sample Size from India="300" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   26/04/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   No 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   300 relatively healthy individuals of either sex will be randomly divided in to two equal groups namely group A and group B Group A individuals will undergo Vaman Karma and group B individuals will undergo Virechan karma. Blood samples for lipid profile will be collected for each individual. On the day before paachan karma, on the day before commencement of Snehapaan, Next day of completion of snehapaan and after completion of SansarjanKrama and followup 15 days after sansarjan karma.In both groups Paachan with panchakolchurna 3gm for 7 days snehapaan with cow ghee in increasing dosage starting dose with 50ml and 25ml dose will be increased daily till the achievement of Samyaksnehalakshana. In group A Vaman will be done with Aakanthapaan of milk, Vamak yoga will be Madanfalpippalichurna 3gm, Kutajbeej churna 2gm, Patola patra 2gm madhu 10ml and saindhav 2gms, Madhuyashti faant with adequate quantity will be used as Vamanopag drug. In group B Triphala, Trivrit, Danti kwath 200ml will be given for Virechan. Total expected duration of completion of this research trial will be approximately 3years.  
Close